Literature DB >> 21309837

Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries.

A M Secrest1, D J Becker, S F Kelsey, R E Laporte, T J Orchard.   

Abstract

AIMS: Type 1 diabetes mellitus increases the risk for sudden unexplained death, generating concern that diabetes processes and/or treatments underlie these deaths. Young (< 50 years) and otherwise healthy patients who are found dead in bed have been classified as experiencing 'dead-in-bed' syndrome.
METHODS: We thus identified all unwitnessed deaths in two related registries (the Children's Hospital of Pittsburgh and Allegheny County) yielding 1319 persons with childhood-onset (age < 18 years) Type 1 diabetes diagnosed between 1965 and 1979. Cause of death was determined by a Mortality Classification Committee (MCC) of at least two physician epidemiologists, based on the death certificate and additional records surrounding the death.
RESULTS: Of the 329 participants who had died, the Mortality Classification Committee has so far reviewed and assigned a final cause of death to 255 (78%). Nineteen (8%) of these were sudden unexplained deaths (13 male) and seven met dead-in-bed criteria. The Mortality Classification Committee adjudicated cause of death in the seven dead-in-bed persons as: diabetic coma (n =4), unknown (n=2) and cardiomyopathy (n=1, found on autopsy). The three dead-in-bed individuals who participated in a clinical study had higher HbA(1c) , lower BMI and higher daily insulin dose compared with both those dying from other causes and those surviving.
CONCLUSIONS: Sudden unexplained death in Type 1 diabetes seems to be increased 10-fold and associated with male sex, while dead-in-bed individuals have a high HbA(1c) and insulin dose and low BMI. Although sample size is too small for definitive conclusions, these results suggest specific sex and metabolic factors predispose to sudden unexplained death and dead-in-bed death.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Year:  2011        PMID: 21309837      PMCID: PMC3045678          DOI: 10.1111/j.1464-5491.2010.03154.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  29 in total

Review 1.  Sudden death in type 1 diabetes.

Authors:  P G McNally; I G Lawrence; R B Panerai; P J Weston; H Thurston
Journal:  Diabetes Obes Metab       Date:  1999-05       Impact factor: 6.577

2.  Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples.

Authors:  G R Warnick; J J Albers
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

3.  Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.

Authors:  T J Orchard; J S Dorman; R E Maser; D J Becker; D Ellis; R E LaPorte; L H Kuller; S K Wolfson; A L Drash
Journal:  Diabetes Care       Date:  1990-07       Impact factor: 19.112

4.  Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999.

Authors:  R Nishimura; R E LaPorte; J S Dorman; N Tajima; D Becker; T J Orchard
Journal:  Diabetes Care       Date:  2001-05       Impact factor: 19.112

Review 5.  Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome?

Authors:  Simon R Heller
Journal:  Int J Clin Pract Suppl       Date:  2002-07

6.  Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system.

Authors:  Robert J Tanenberg; Christopher A Newton; Almond J Drake
Journal:  Endocr Pract       Date:  2010 Mar-Apr       Impact factor: 3.443

7.  The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results.

Authors:  J S Dorman; R E Laporte; L H Kuller; K J Cruickshanks; T J Orchard; D K Wagener; D J Becker; D E Cavender; A L Drash
Journal:  Diabetes       Date:  1984-03       Impact factor: 9.461

8.  Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics.

Authors:  E A Gale; R B Tattersall
Journal:  Lancet       Date:  1979-05-19       Impact factor: 79.321

9.  Unexplained deaths of type 1 diabetic patients.

Authors:  R B Tattersall; G V Gill
Journal:  Diabet Med       Date:  1991-01       Impact factor: 4.359

10.  International evaluation of cause-specific mortality and IDDM. Diabetes Epidemiology Research International Mortality Study Group.

Authors: 
Journal:  Diabetes Care       Date:  1991-01       Impact factor: 19.112

View more
  18 in total

1.  Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Authors:  Rayhan A Lal; Laya Ekhlaspour; Korey Hood; Bruce Buckingham
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

2.  IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.

Authors:  Yu Kuei Lin; Man Hung; Anu Sharma; Owen Chan; Michael W Varner; Gitana Staskus; Simon J Fisher
Journal:  Endocr Pract       Date:  2019-03-13       Impact factor: 3.443

3.  Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in children with type 1 diabetes.

Authors:  Sara Bachmann; Anne Auderset; Marie-Anne Burckhardt; Gabor Szinnai; Melanie Hess; Urs Zumsteg; Kris Denhaerynck; Birgit Donner
Journal:  Pediatr Diabetes       Date:  2021-09-17       Impact factor: 3.409

4.  Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic Analysis.

Authors:  Clara Mosquera-Lopez; Robert Dodier; Nichole S Tyler; Leah M Wilson; Joseph El Youssef; Jessica R Castle; Peter G Jacobs
Journal:  Diabetes Technol Ther       Date:  2020-05-14       Impact factor: 6.118

5.  Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Authors:  Ashley Pinckney; Mark R Rigby; Lynette Keyes-Elstein; Carol L Soppe; Gerald T Nepom; Mario R Ehlers
Journal:  Clin Ther       Date:  2016-05-18       Impact factor: 3.393

6.  Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation.

Authors:  Candace M Reno; Dorit Daphna-Iken; Y Stefanie Chen; Jennifer VanderWeele; Krishan Jethi; Simon J Fisher
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

7.  Diabetic Dead-in-Bed Syndrome: A Possible Link to a Cardiac Ion Channelopathy.

Authors:  Jonathan R Skinner; Renate Marquis-Nicholson; Alix Luangpraseuth; Rick Cutfield; Jackie Crawford; Donald R Love
Journal:  Case Rep Med       Date:  2014-02-19

Review 8.  Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children.

Authors:  Vanessa Rodrigues Vilela; Any de Castro Ruiz Marques; Christiano Rodrigues Schamber; Roberto Barbosa Bazotte
Journal:  ScientificWorldJournal       Date:  2014-03-23

9.  Even silent hypoglycemia induces cardiac arrhythmias.

Authors:  Amy L Clark; Conor J Best; Simon J Fisher
Journal:  Diabetes       Date:  2014-05       Impact factor: 9.461

10.  Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.

Authors:  Lalantha Leelarathna; Stuart A Little; Emma Walkinshaw; Horng Kai Tan; Alexandra Lubina-Solomon; Kavita Kumareswaran; Annette P Lane; Thomas Chadwick; Sally M Marshall; Jane Speight; Daniel Flanagan; Simon R Heller; James A M Shaw; Mark L Evans
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.